Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar

被引:7
|
作者
Naushad, Vamanjore A. [1 ,4 ,5 ]
Purayil, Nishan K. [1 ,4 ,5 ]
Wilson, Godwin J. [2 ,5 ]
Chandra, Prem [3 ]
Joseph, Prakash [1 ,4 ]
Khalil, Zahida [1 ,4 ]
Zahid, Muhammad [1 ,5 ]
Kayakkool, Muhammed K. [1 ,4 ,5 ]
Shaik, Noorjahan [1 ]
Ayari, Basma [1 ,5 ]
Chalihadan, Sajid [1 ]
Elmagboul, Emad Basheir I. [2 ]
Doiphode, Sanjay H. [2 ,5 ]
机构
[1] Hamad Gen Hosp, Gen Internal Med Dept, Hamad Med Corp, Doha, Qatar
[2] Hamad Med Corp, Dept Microbiol, Doha, Qatar
[3] Hamad Med Corp, Med Res Ctr, Doha, Qatar
[4] Qatar Univ, Coll Med, Doha, Qatar
[5] Weill Cornell Med, Ar Rayyan, Qatar
来源
IJID REGIONS | 2022年 / 3卷
关键词
ESBL; Urinary tract infections; Extended-spectrum beta-lactamase; Antibiotics; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE TRENDS; COMMUNITY; SUSCEPTIBILITY; PREVALENCE; BACTERIA; CARE;
D O I
10.1016/j.ijregi.2022.05.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Community-acquired urinary tract infection (UTI) is the most common infection caused by extended -spectrum beta-lactamase (ESBL)-producing organisms. Aim: to estimate the prevalence of ESBL-UTI in adults and to identify potential risk factors that may predispose to ESBL-UTI. Methods: A retrospective study involving adult patients with UTI caused by ESBL-producing organisms was undertaken. Patients with UTI caused by non-ESBL-producing organisms represented the control group. Results: In total, 1100 UTI isolates were included in the study, 277 of which were ESBL positive. The prevalence rate was 25.2%. The mean age of patients was 55.87 years. On univariate analysis, prior history of UTI or ESBL-UTI, invasive urological procedure within preceding 3 months, hospital admission within preceding 3 months, and exposure to antibiotics were found to be significant risk factors for ESBL-UTI. On multi-variate analysis, use of cephalosporins [adjusted odds ratio (OR) 1.61, P = 0.048], previous ESBL-UTI (adjusted OR 2.67, P < 0.001), and invasive urological procedure in the preceding year (adjusted OR 1.61, P = 0.022) were found to be independent risk factors for ESBL-UTI. Conclusions: In Qatar, the prevalence of ESBL-UTI in adults is modest. Recent exposure to antibiotics, previous ESBL-UTI and invasive urological procedures were found to be independent risk factors for ESBL-UTI.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [1] Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria
    Briongos-Figuero, L. S.
    Gomez-Traveso, T.
    Bachiller-Luque, P.
    Dominguez-Gil Gonzalez, M.
    Gomez-Nieto, A.
    Palacios-Martin, T.
    Gonzalez-Sagrado, M.
    Duenas-Laita, A.
    Perez-Castrillon, J. L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (09) : 891 - 896
  • [2] Prevalence of extended spectrum beta-lactamase (ESBL) and AmpC beta-lactamase producing bacteria in urinary tract infection patients in Bangladesh
    Mitu, Farhana Sultana
    Al Maruf, Md Abdullah
    Mahanty, Arpan
    Huda, A. K. M. Nazmul
    Khan, Sabbir Ahmed
    Rahman, M. Mushfequr
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2019, 15 (03) : 204 - 212
  • [3] Controversies in treating febrile infantile urinary tract infection caused by extended-spectrum beta-lactamase producing Enterobacteriaceae: an international multi-centre survey
    Wong, Sze Wa
    Tullus, Kjell
    Chan, Yu Hin Eugene
    PEDIATRIC NEPHROLOGY, 2025,
  • [4] Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
    Bock, Lukas
    Aguilar-Bultet, Lisandra
    Egli, Adrian
    Battegay, Manuel
    Kronenberg, Andreas
    Vogt, Roland
    Kaufmann, Carole
    Tschudin-Sutter, Sarah
    ENVIRONMENTAL RESEARCH, 2022, 215
  • [5] Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study
    Almomani, Basima A.
    Hayajneh, Wail A.
    Ayoub, Abeer M.
    Ababneh, Mera A.
    Al Momani, Miral A.
    INFECTION, 2018, 46 (04) : 495 - 501
  • [6] Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from bean sprouts in the Netherlands
    Huizinga, Pepijn
    Schrauwen, Eefje
    Garcia-Cobos, Silvia
    Willemsen, Ina
    Verhulst, Carlo
    Friedrich, Alexander W.
    Savelkoul, Paul H. M.
    Rossen, John W.
    Kluytmans, Jan
    PLOS ONE, 2018, 13 (08):
  • [7] Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
    Bielen, Luka
    Likic, Robert
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2019, 6 : 1 - 11
  • [8] Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon
    Djim-Adjim-Ngana, Karyom
    Mbiakop, Brunel W.
    Oumar, Leila A.
    Njifon, Hermann Munshili L.
    Tchinda Fossi, Cedric
    Enyegue, Elisee L. Embolo
    Mouliom, Mohamed Mouiche M.
    Chegaing, Simeon P. Fodouop
    Deweerdt, Louis
    Yanou, Nicolas Njintang
    Nguinkal, Julien A.
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [9] Extended-spectrum beta-lactamase producing-enterobacteriaceae
    Mariani-Kurkdjian, P.
    Doit, C.
    Bingen, E.
    ARCHIVES DE PEDIATRIE, 2012, 19 : S93 - S96
  • [10] Association Between Proton Pump Inhibitor Use and Extended-Spectrum Beta-Lactamase Urinary Tract Infection in Adults: A Retrospective Study
    Purayil, Nishan Kunnummal
    Naushad, Vamanjore A.
    Chandra, Prem
    Joseph, Prakash
    Khalil, Zahida
    Zahid, Muhammad
    Wilson, Godwin
    Kayakkool, Muhammed Kunhi
    Ayari, Basma
    Chalihadan, Sajid
    Elmagboul, Emad Bashier, I
    Doiphode, Sanjay H.
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 4251 - 4258